Mutual Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Mutual Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Sell	5,289 -190	-3%	-$40.9K	0.02%	553
2026 Q1	$1.1M	Hold	5,479	–	–	0.02%	562
2025 Q4	$1.13M	Sell	5,479 -1	-0%	-$200	0.02%	536
2025 Q3	$1.04M	Buy	5,480 +274	+5%	+$46.7K	0.02%	560
2025 Q2	$865K	Buy	5,206 +102	+2%	+$16.2K	0.02%	567
2025 Q1	$814K	Buy	5,104 +10	+0.2%	+$1.74K	0.02%	526
2024 Q4	$888K	Sell	5,094 -10	-0.2%	-$1.71K	0.03%	518
2024 Q3	$858K	Buy	5,104 +82	+2%	+$13.6K	0.03%	534
2024 Q2	$833K	Sell	5,022 -151	-3%	-$22.7K	0.03%	546
2024 Q1	$795K	Sell	5,173 -147	-3%	-$22.4K	0.03%	552
2023 Q4	$841K	Sell	5,320 -239	-4%	-$34.3K	0.03%	506
2023 Q3	$814K	Sell	5,559 -166	-3%	-$25.3K	0.03%	480
2023 Q2	$877K	Buy	5,725 +79	+1%	+$12.3K	0.03%	469
2023 Q1	$875K	Sell	5,646 -106	-2%	-$16.6K	0.04%	459
2022 Q4	$887K	Buy	+5,752	New	+$849K	0.04%	438
2022 Q3	–	Sell	-5,841	Closed	-$792K	–	893
2022 Q2	$792K	Sell	5,841 -336	-5%	-$46.3K	0.05%	402
2022 Q1	$921K	Sell	6,177 -70	-1%	-$10.4K	0.05%	402
2021 Q4	$1.01M	Buy	6,247 +160	+3%	+$25.9K	0.05%	382
2021 Q3	$1.01M	Sell	6,087 -1,282	-17%	-$219K	0.06%	352
2021 Q2	$1.27M	Sell	7,369 -108	-1%	-$17.8K	0.08%	307
2021 Q1	$1.2M	Buy	7,477 +66	+0.9%	+$11.3K	0.08%	292
2020 Q4	$1.25M	Sell	7,411 -195	-3%	-$31.6K	0.09%	260
2020 Q3	$1.2M	Buy	7,606 +339	+5%	+$55.4K	0.1%	209
2020 Q2	$1.22M	Buy	7,267 +2,153	+42%	+$338K	0.12%	187
2020 Q1	$671K	Buy	5,114 +55	+1%	+$7.84K	0.09%	234
2019 Q4	$752K	Buy	5,059 +2,621	+108%	+$360K	0.08%	268
2019 Q3	$302K	Sell	2,438 -468	-16%	-$62.3K	0.04%	417
2019 Q2	$409K	Buy	2,906 +1,291	+80%	+$178K	0.05%	367
2019 Q1	$244K	Buy	+1,615	New	+$232K	0.04%	403

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Mutual Advisors's FBT Position: Q2 2026 in Review

Mutual Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.5% in Q2 2026, selling an estimated $40.9K and leaving 5,289 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #553.

Mutual Advisors first reported a position in FBT in Q1 2019 and has held it in 29 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Mutual Advisors held 5,289 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.31M as of Q2 2026.
Mutual Advisors sold 190 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $40.9K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Mutual Advisors's portfolio in Q2 2026, its #553 holding.
Mutual Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 29 quarters since.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.